Identification of Regional Epidemiological Characteristics and Key Prognostic Factors of Colorectal Cancer in Xinjiang and Shandong
1 other identifier
observational
500
1 country
1
Brief Summary
This is a multicenter, retrospective, cross-sectional observational study aiming to investigate the 5-year overall survival (OS) rate of colorectal cancer (CRC) patients in Xinjiang and Shandong provinces of China. A total of no less than 500 pathologically confirmed CRC patients from 7 medical centers during January 1, 2016 to December 31, 2020 will be enrolled. We will collect and analyze the demographic characteristics, lifestyle, clinical pathological features, treatment patterns and survival prognosis data of patients, explore the regional differences of CRC and its key prognostic factors, and construct a CRC prognostic prediction model. The results will provide theoretical guidance for clinical practice and the formulation of public health policies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedFirst Submitted
Initial submission to the registry
April 6, 2026
CompletedFirst Posted
Study publicly available on registry
April 13, 2026
CompletedApril 13, 2026
February 1, 2026
5 years
April 6, 2026
April 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
5-year Overall Survival
Five-year overall survival rate of patients with colorectal cancer, defined as the time from pathological diagnosis to death from any cause or last follow-up.
5 years
Study Arms (2)
Group/Cohort Label 1:Xinjiang CRC Cohort
Retrospective collection and analysis of clinical, pathological and follow-up data of pathologically confirmed colorectal cancer patients from medical centers in Xinjiang region, including demographic characteristics, lifestyle, treatment patterns and 5-year overall survival status.
Group/Cohort Label 2:Shandong CRC Cohort
Retrospective collection and analysis of clinical, pathological and follow-up data of pathologically confirmed colorectal cancer patients from medical centers in Shandong region, including demographic characteristics, lifestyle, treatment patterns and 5-year overall survival status.
Interventions
Retrospective collection, collation and statistical analysis of de-identified clinical, pathological, treatment and follow-up data of pathologically confirmed colorectal cancer patients from 7 medical centers in Xinjiang and Shandong provinces from January 1, 2016 to December 31, 2020. The collected data includes demographic characteristics, lifestyle, tumor clinical pathological features, treatment patterns and 5-year overall survival status, for the purpose of analyzing regional epidemiological characteristics and key prognostic factors of colorectal cancer.
Eligibility Criteria
This is a retrospective, cross-sectional, multicenter observational study. The study population includes patients pathologically diagnosed with colorectal adenocarcinoma between January 1, 2016 and December 31, 2020 from medical centers in Xinjiang Uygur Autonomous Region and Shandong Province. Patients aged 18 years and above with complete clinical, pathological, treatment and follow-up data will be included. The study aims to analyze the regional epidemiological characteristics and prognostic factors of colorectal cancer.
You may qualify if:
- \. Pathologically confirmed colorectal adenocarcinoma.
- \. Patients diagnosed between January 1, 2016 and December 31, 2020.
- \. Age ≥ 18 years old.
- \. Complete clinical, pathological, treatment and follow-up data available.
- \. Patients from medical centers in Xinjiang and Shandong regions.
You may not qualify if:
- \. Other pathological types of malignant tumors except colorectal adenocarcinoma.
- \. Patients with incomplete clinical data or lost to follow-up.
- \. Patients with severe organ dysfunction or other malignant tumors that may affect survival.
- \. Age \< 18 years old.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
the Qianfoshan Hospital
Jinan, Shandong, 250000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 6, 2026
First Posted
April 13, 2026
Study Start
January 1, 2016
Primary Completion
December 31, 2020
Study Completion
December 31, 2020
Last Updated
April 13, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share individual participant data (IPD) from this study. Data will be used only for the purpose of this retrospective observational study and will not be shared with third parties.